179 related articles for article (PubMed ID: 25873590)
41. Read-Split-Run: an improved bioinformatics pipeline for identification of genome-wide non-canonical spliced regions using RNA-Seq data.
Bai Y; Kinne J; Donham B; Jiang F; Ding L; Hassler JR; Kaufman RJ
BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):503. PubMed ID: 27556805
[TBL] [Abstract][Full Text] [Related]
42. Construction and analysis of lncRNA-lncRNA synergistic networks to reveal clinically relevant lncRNAs in cancer.
Li Y; Chen J; Zhang J; Wang Z; Shao T; Jiang C; Xu J; Li X
Oncotarget; 2015 Sep; 6(28):25003-16. PubMed ID: 26305674
[TBL] [Abstract][Full Text] [Related]
43. A multiple genomic data fused SF2 prediction model, signature identification, and gene regulatory network inference for personalized radiotherapy.
He QE; Tong YF; Ye Z; Gao LX; Zhang YZ; Wang L; Song K
Technol Cancer Res Treat; 2020; 19():1533033820909112. PubMed ID: 32329416
[TBL] [Abstract][Full Text] [Related]
44. SRSF1-Regulated Alternative Splicing in Breast Cancer.
Anczuków O; Akerman M; Cléry A; Wu J; Shen C; Shirole NH; Raimer A; Sun S; Jensen MA; Hua Y; Allain FH; Krainer AR
Mol Cell; 2015 Oct; 60(1):105-17. PubMed ID: 26431027
[TBL] [Abstract][Full Text] [Related]
45. Inferring regulatory element landscapes and transcription factor networks from cancer methylomes.
Yao L; Shen H; Laird PW; Farnham PJ; Berman BP
Genome Biol; 2015 May; 16(1):105. PubMed ID: 25994056
[TBL] [Abstract][Full Text] [Related]
46. Low duplicability and network fragility of cancer genes.
Rambaldi D; Giorgi FM; Capuani F; Ciliberto A; Ciccarelli FD
Trends Genet; 2008 Sep; 24(9):427-30. PubMed ID: 18675489
[TBL] [Abstract][Full Text] [Related]
47. KatzDriver: A network based method to cancer causal genes discovery in gene regulatory network.
Akhavan-Safar M; Teimourpour B
Biosystems; 2021 Mar; 201():104326. PubMed ID: 33309969
[TBL] [Abstract][Full Text] [Related]
48. DrGaP: a powerful tool for identifying driver genes and pathways in cancer sequencing studies.
Hua X; Xu H; Yang Y; Zhu J; Liu P; Lu Y
Am J Hum Genet; 2013 Sep; 93(3):439-51. PubMed ID: 23954162
[TBL] [Abstract][Full Text] [Related]
49. Exonization of transposed elements: A challenge and opportunity for evolution.
Schmitz J; Brosius J
Biochimie; 2011 Nov; 93(11):1928-34. PubMed ID: 21787833
[TBL] [Abstract][Full Text] [Related]
50. Engineering DYRK1A overdosage yields Down syndrome-characteristic cortical splicing aberrations.
Toiber D; Azkona G; Ben-Ari S; Torán N; Soreq H; Dierssen M
Neurobiol Dis; 2010 Oct; 40(1):348-59. PubMed ID: 20600907
[TBL] [Abstract][Full Text] [Related]
51. Finding microRNA regulatory modules in human genome using rule induction.
Tran DH; Satou K; Ho TB
BMC Bioinformatics; 2008 Dec; 9 Suppl 12(Suppl 12):S5. PubMed ID: 19091028
[TBL] [Abstract][Full Text] [Related]
52. Identification of deregulation mechanisms specific to cancer subtypes.
Champion M; Chiquet J; Neuvial P; Elati M; Radvanyi F; Birmelé E
J Bioinform Comput Biol; 2021 Feb; 19(1):2140003. PubMed ID: 33653235
[TBL] [Abstract][Full Text] [Related]
53. Transcriptome-Wide Detection of Intron/Exon Definition in the Endogenous Pre-mRNA Transcripts of Mammalian Cells and Its Regulation by Depolarization.
Liu L; Das U; Ogunsola S; Xie J
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077555
[TBL] [Abstract][Full Text] [Related]
54. DEOD: uncovering dominant effects of cancer-driver genes based on a partial covariance selection method.
Amgalan B; Lee H
Bioinformatics; 2015 Aug; 31(15):2452-60. PubMed ID: 25819079
[TBL] [Abstract][Full Text] [Related]
55. A novel network control model for identifying personalized driver genes in cancer.
Guo WF; Zhang SW; Zeng T; Li Y; Gao J; Chen L
PLoS Comput Biol; 2019 Nov; 15(11):e1007520. PubMed ID: 31765387
[TBL] [Abstract][Full Text] [Related]
56. Purifying Selection on Exonic Splice Enhancers in Intronless Genes.
Savisaar R; Hurst LD
Mol Biol Evol; 2016 Jun; 33(6):1396-418. PubMed ID: 26802218
[TBL] [Abstract][Full Text] [Related]
57. The mutational landscape of phosphorylation signaling in cancer.
Reimand J; Wagih O; Bader GD
Sci Rep; 2013 Oct; 3():2651. PubMed ID: 24089029
[TBL] [Abstract][Full Text] [Related]
58. Changes in exon-intron structure during vertebrate evolution affect the splicing pattern of exons.
Gelfman S; Burstein D; Penn O; Savchenko A; Amit M; Schwartz S; Pupko T; Ast G
Genome Res; 2012 Jan; 22(1):35-50. PubMed ID: 21974994
[TBL] [Abstract][Full Text] [Related]
59. RNA analysis reveals splicing mutations and loss of expression defects in MLH1 and BRCA1.
Sharp A; Pichert G; Lucassen A; Eccles D
Hum Mutat; 2004 Sep; 24(3):272. PubMed ID: 15300854
[TBL] [Abstract][Full Text] [Related]
60. Background splicing as a predictor of aberrant splicing in genetic disease.
D A; Y L; R S; H D; E B; Rm W; I V; L C; N J D
RNA Biol; 2022; 19(1):256-265. PubMed ID: 35188075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
